SMC clears use of five news drugs on NHS Scotland
Scottish cost regulators have endorsed the use of five new medicines by NHS Scotland, offering patients new options for lung cancer, depression, ankylosing spondylitis and epilepsy.
Read More
Tag: Brintellix
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
